Related Experiment Video

Updated: Jan 27, 2026

Tracking Bispecific Antibody-Induced T Cell Trafficking Using Luciferase-Transduced Human T Cells
10:19

Tracking Bispecific Antibody-Induced T Cell Trafficking Using Luciferase-Transduced Human T Cells

Published on: May 12, 2023

1.6K

Bispecific Antibody (bsAb) Construct Formats and their Application in Cancer Therapy

Desmond O Acheampong1

  • 1Department of Biomedical Sciences, School of Allied Health Sciences, College of Health and Allied Science, University of Cape Coast, Cape Coast, Ghana.

Protein and Peptide Letters
|March 14, 2019
PubMed

Insights

Bispecific antibodies (bsAbs) offer superior cancer treatment by simultaneously targeting multiple signaling pathways. This review explores bsAb engineering formats and their therapeutic applications.

Area of Science:

  • Oncology
  • Immunotherapy
  • Biotechnology

Background:

  • Cancer development involves complex, multi-signal pathways, necessitating multi-targeted therapeutic strategies.
  • Conventional monoclonal antibodies are effective but often require combination therapy for optimal activity.
  • Combination therapy with multiple monoclonal antibodies shows promise but faces challenges in efficacy and delivery.

Purpose of the Study:

  • To review the engineering formats of bispecific antibodies (bsAbs).
  • To highlight the superior therapeutic potential of bsAbs over combination therapies.
  • To discuss the applications of bsAbs in cancer treatment.

Main Methods:

  • Literature review of bispecific antibody engineering techniques.
  • Comparative analysis of bsAb efficacy versus combination monoclonal antibody therapy.
  • Exploration of diverse bsAb formats and their clinical relevance.

Main Results:

  • Bispecific antibodies engineered from monoclonal antibodies demonstrate enhanced activity compared to combination therapy.
  • bsAbs can simultaneously target multiple cancer signaling pathways, offering a more effective treatment approach.
  • Various bsAb engineering formats exist, each with unique properties and applications.

Conclusions:

  • Bispecific antibodies represent a promising therapeutic agent for complex cancers.
  • The ability of bsAbs to target multiple pathways simultaneously offers a significant advantage in cancer treatment.
  • Further research into bsAb engineering and applications is warranted for optimizing cancer therapy.
Keywords:
Bispecific antibodiescancers/tumorscombination therapymonoclonal antibodiesmonotherapytherapeutic agent.

More Related Videos

A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity11:13

A GPC3-targeting Bispecific Antibody, GPC3-S-Fab, with Potent Cytotoxicity

Published on: July 12, 2018

9.2K
Cerenkov Luminescence Imaging CLI for Cancer Therapy Monitoring08:45

Cerenkov Luminescence Imaging CLI for Cancer Therapy Monitoring

Published on: November 13, 2012

14.3K

Related Concept Videos

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
10.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
8.9K
Antibody Structure01:10

Antibody Structure

Overview
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
65.5K
Gene Therapy00:59

Gene Therapy

Gene therapy is a technique where a gene is inserted into a person’s cells to prevent or treat a serious disease. The added gene may be a healthy version of the gene that is mutated in the patient, or it could be a different gene that inactivates or compensates for the patient’s disease-causing gene. For example, in patients with severe combined immunodeficiency (SCID) due to a mutation in the gene for the enzyme adenosine deaminase, a functioning version of the gene can be...
27.6K
Formation of Species01:31

Formation of Species

Speciation describes the formation of one or more new species from one or sometimes multiple original species. The resulting species are discrete from the parent species, and barriers to reproduction will typically exist. There are two primary mechanisms, speciation with and without geographic isolation—allopatric and sympatric speciation, respectively.
44.9K
Solution Formation02:16

Solution Formation

There is no one solvent that can dissolve every type of solute. Some substances that readily dissolve in a certain solvent might be insoluble in a different solvent. A simple way to predict which substances dissolve in which solvent is the phrase "like dissolves like". This means that polar substances, such as salt and sugar, dissolve in a polar substance like water. In contrast, non-polar substances are more soluble in non-polar solvents such as carbon tetrachloride.
This selective...
37.4K